http://investors.aastrom.com/releases.cfm?sh_auth=0.0.0.ad1dcb691ef81696c0c02ea27e385165Aastrom Biosciences, Inc. - All News Releasesen-usShareholder.com RSS Feedhttp://investors.aastrom.com/releasedetail.cfm?ReleaseID=763189Wed, 08 May 2013 04:00:00 GMThttp://investors.aastrom.com/releasedetail.cfm?ReleaseID=763189Aastrom Biosciences Reports First Quarter 2013 Financial Resultshttp://investors.aastrom.com/releasedetail.cfm?ReleaseID=761934Fri, 03 May 2013 04:00:00 GMThttp://investors.aastrom.com/releasedetail.cfm?ReleaseID=761934Aastrom to Host First Quarter 2013 Investor Call on May 8, 2013http://investors.aastrom.com/releasedetail.cfm?ReleaseID=759544Thu, 25 Apr 2013 04:00:00 GMThttp://investors.aastrom.com/releasedetail.cfm?ReleaseID=759544Aastrom to Hold Annual Meeting of Shareholders on May 2, 2013http://investors.aastrom.com/releasedetail.cfm?ReleaseID=757729Fri, 19 Apr 2013 04:00:00 GMThttp://investors.aastrom.com/releasedetail.cfm?ReleaseID=757729Aastrom Biosciences Announces First Patients Treated in ixCELL-DCM Clinical Study of ixmyelocel-Thttp://investors.aastrom.com/releasedetail.cfm?ReleaseID=755357Tue, 09 Apr 2013 04:00:00 GMThttp://investors.aastrom.com/releasedetail.cfm?ReleaseID=755357Aastrom Biosciences to Present at Multiple Conferences in Aprilhttp://investors.aastrom.com/releasedetail.cfm?ReleaseID=754283Thu, 04 Apr 2013 04:00:00 GMThttp://investors.aastrom.com/releasedetail.cfm?ReleaseID=754283Aastrom Biosciences Announces First Patients Enrolled in ixCELL-DCM Phase 2b Clinical Trial of Ixmyelocel-Thttp://investors.aastrom.com/releasedetail.cfm?ReleaseID=751404Wed, 27 Mar 2013 04:00:00 GMThttp://investors.aastrom.com/releasedetail.cfm?ReleaseID=751404Aastrom Biosciences Announces Strategic Change in Research and Development Programs to Focus on Dilated Cardiomyopathy and Other Rare Disease Indicationshttp://investors.aastrom.com/releasedetail.cfm?ReleaseID=749228Mon, 18 Mar 2013 04:00:00 GMThttp://investors.aastrom.com/releasedetail.cfm?ReleaseID=749228Aastrom Biosciences Reports Fourth-Quarter and Year-End 2012 Financial Resultshttp://investors.aastrom.com/releasedetail.cfm?ReleaseID=747609Tue, 12 Mar 2013 04:00:00 GMThttp://investors.aastrom.com/releasedetail.cfm?ReleaseID=747609Aastrom to Host Fourth Quarter 2012 Investor Call on March 18, 2013http://investors.aastrom.com/releasedetail.cfm?ReleaseID=746042Wed, 06 Mar 2013 05:00:00 GMThttp://investors.aastrom.com/releasedetail.cfm?ReleaseID=746042Aastrom Board of Directors Names Dominick C. Colangelo President and Chief Executive Officer